-
一、抗原肽诱导
CTL
制备
were
separated
from
the
whole
blood
of
HLA-A2+
healthy
controls.
PBMCs (2 x10
6
/ml)
were cultured with each of the HLAA* 0201
refolding peptides
at a concentration
of 10 uM in RPMI 1640 medium containing 10% FCS
and 20 U/ml
recombinant human IL-2
(rhIL-2) in 24-well culture plate. Half of the
medium was
changed
at
day
4
with
supplementation
of
rhIL-2
at
20
U/ml.
At
day
7,
cells
were
harvested and tested for the presence
of peptide-specific CD8+ T cells by an
IFN-
γ
release
ELISPOT assay.
---------------
Zhou M, Xu D,
Li X, Li H, Shan M, Tang J, Wang M, Wang FS, Zhu
X,
Tao H
et
al
: Screening and identification of
severe acute respiratory
syndrome-associated coronavirus-
specific CTL epitopes.
J
Immunol
2006,
177(4):2138-2145.
2. PBMCs were separated
from heparinized venous blood by Ficoll-Hypaque
density
gradient
centrifugation
from
HLAA*0201
normal
donors
and
HCC
patients.
DCs
were
generated
from
peripheral
blood
monocytes
as
described
by
Romani.
Briefly,
PBMCs were seeded into six-well culture
plates containing 3 ml RPMI-1640 and 10%
FCS
at5
–
10x10
6
/well.
Plates
were
incubated
in
a
37
o
C
incubator
for
2
h,
then
the
non-adherent
cells
were
removed
and
the
adherent
cells
were
cultured
at
37
o
C
in
RPMI-1640 supplemented
with 10% FCS, 1000 U/ml human recombinant GM-CSF
and 500 U/ml human recombinant IL-4.
All T cell stimulation was with day 7 DCs.
As described below, DCs were matured
with lipopolysaccharide (LPS) on day 6 and
HCA587 antigen was added for effective
processing at this time.
Day
6
DCs
were
resuspended
in
RPMI-1640
with
1000
U/ml
GM-CSF,
500
U/ml IL-4 and 10 ng/ml
LPS and incubated at 37
o
C.
After 24 h cultivation the DCs
were
collected, washed and pulsed with 10 m g/ml HCA587
peptide for 3 h at 37
o
C.
The DCs were washed twice for the
following stimulation.
CD8+
T
cells
were
isolated
by
positive
selection
with
CD8-Dynal
immunomagnetic beads according to the
manufacturer’s instructions.
After washing,
CD8+T cells
were co-cultured with HCA587
peptide-loaded DCs in 2 ml RPMI-1640
medium supplemented
with 10% AB serum, recombinant human
IL-2
(10 ng/ml) and
IL-6 (500 U/ml). Seven days later, the
cultured
T cells were
restimulated with freshly
prepared
peptide-
pulsed DCs and
cultured for another 7 days. After four
consecutive
rounds
of
stimulation,
cultures
were
tested
for
the
presence
of
HCA587-specific
CTLs.
-----------
Li
B,
Wang
Y,
Chen
J,
Wu
H,
Chen
W:
Identification
of
a
new
HLA-A*0201-restricted
CD8+
T
cell
epitope
from
hepatocellular
carcinoma-associated antigen HCA587.
Clin Exp Immunol
2005,
140(2):310-319.
tion of CTLs in PBMCs from healthy
donors
:
Dendritic
cells
(DCs)
have
the
unique
capacity
of
activating
naive
T
cells
and
initiating primary T-cell response.
Antigen-specific T-cell responses from peripheral
blood
mononuclear
cells
(PBMCs)
can
be
elicited
with
antigenic
peptide-pulsed
autologous
DCs.
We
obtained
PBMCs
from
the
buffy
coat
of
heparinized
whole
blood samples of healthy donors by
density gradient centrifugation on the Histopaque
1077. These cells were resuspended in
serum-free RPMI 1640 and allowed to adhere
to
six
well
plates
at
a
final
concentration
of
1
x
10
7
cells/3
ml/
well.
After
2
h
of
incubation at
37°
C, non-adherent
cells
were gently removed with warm medium by
gently pipetting. The non-adherent
cells (effector lymphocytes) were cryopreserved in
FCS supplemented by 10% DMSO. The
resultant adherent cells containing DCs were
cultured
in
medium
supplemented
with
800
U/ml
GMCSF
and
1,000
U/ml
IL-4
in
37°
C/5%
CO
2
. Every 2 days, one-half
of the medium was replaced by fresh medium
containing a double concentration of
GM-CSF and IL-4 as indicated above. On day 5,
10
ng/ml
of
recombinant
human
tumor
necrosis
factor
a
(TNF-
a
)
was
added
to
the
medium
to
induce
phenotypic
and
functional
maturation
of
DCs.
After
48
h,
DCs
were
pulsed
with
20
ug/ml
peptide in the
presence of 3
ug/ml
b2-
microglobulin
at
37°
C for 3 h and irradiated
at 30 Gy before use. The thawed 2 x10
6
of non-adherent
effector
lymphocytes were cocultured with 2
x10
5
peptidepulsed
irradiated autologous
DCs in a 24-well
plate in the presence of 10 ng/ml recombinant
human interleukin-7
(IL-7). After 7
days, lymphocytes were restimulated with peptide-
pulsed autologous
PBMCs
in
medium
containing 10 ng/ml
IL-7 and
20 U/ml IL-2. About
20 U/ml of
IL-2
was
added
24
h
later
at
regular
intervals,
2
days
after
each
restimulation.
Lymphocytes were restimulated each week
in the same manner. On the seventh day,
after the three rounds of
restimulation, cells were harvested and tested by
ELISPOT
assay.
--------------
An
altered
peptide
ligand
for
nave
cytotoxic
T
lymphocyte
epitope
of
TRP-2(180
–
188)
enhanced immunogenicity.
Cancer Immunol
Immunother (2007) 56:319
–
329
第三军医大
吴玉章
tion of CTLs in healthy donors
Dendritic cells are characterized by
the unique capacity to activate naive T cells and
initiate
primary
T-cell
response.
Antigen-specific
T-cell
responses
from
peripheral
blood
mononuclear
cells
(PBMCs)
can
be
elicited
with
antigenic
peptide-
or
protein-pulsed autologous
DCs. Here, PBMCs were isolated from whole blood of
11
healthy
HLA-A2.1
_
volunteer
donors
by
Ficoll/Hypaque
density
gradient
centrifugation.
Human
peripheral
blood
monocyte-derived
DCs
were
generated
as
previously described by us. On day 5 of
culture, 10 ng/mL recombinant human tumor
necrosis
factor
was
added
to
the
medium
to
induce
phenotypic
and
functional
maturation.
Then,
48
hours
later,
DCs
were
pulsed
with
20
ug/mL
peptide
in
the
presence of 3 ug/mL
B2-microglobulin at 37°
C for
3 hours and irradiated at 30 Gy
before
use.
Peripheral
blood
lymphocytes
(PBLs,
2
x10
6
)
were
cocultured
with
2
x
10
5
peptide-
pulsed irradiated autologous DCs in a 24-well
plate in the presence of 10
ng/mL
recombinant
human
interleukin-7.
The
next
day,
recombinant
human
IL-10
was added
to the culture medium, to give a final
concentration of 10 ng/mL. After 7
days, lymphocytes were restimulated
with peptide-pulsed irradiated autologous DCs
in
medium
containing
10
ng/mL
IL-7
and
10
ng/mL
IL-10,
and
then
supplemented
with 20 IU/mL
IL-2 24 hours later. Lymphocytes were restimulated
each week in the
same manner. At 7 days
after the fourth round of restimulation, cells
were harvested
and
tested
by
ELISPOT
assay,
cytotoxicity
assay,
and
tetramer
staining.
CD8T
lymphocytes
were
purified
by
CD4_
cell
–
negative
depletion
using
human
CD4
microbeads.
---------
Wang B, Chen H,
Jiang X, Zhang M, Wan T, Li N, Zhou X, Wu Y, Yang
F,
Yu
Y
et
al
:
Identification
of
an
HLA-A*0201-restricted
CD8+
T-cell
epitope
SSp-1
of
SARS-CoV
spike
protein.
Blood
2004,
104
(1):200-206.
第二军医大
曹
雪涛
5.
抗原肽诱导
CTL
制备:
密度梯度离心法分离经
EDAT
抗凝的静脉血中的外周血单个核细胞(
perip
heral
blood
mononuclear
cells
,
PBMC)
,分离得到的
PBMC
种于
6
孔细胞培养板,在
含
10%FCS
的
RPMI1640
培养基中,
< br>37
℃
5%CO2
孵育
1.5h
。
收集悬浮细胞
(
主要
为淋巴细胞
)
,以
10%
二甲亚矾
90%<
/p>
小牛血清保存于液氮备用。贴壁细胞为抗原
提呈细胞
-
树突状细胞
(DC)
前体
细胞,补充含
GM-CSF(l000U/ml
,
R&D)
、
IL-4(l000U/ml
,
R&D)
及含
10%F
CS
的
RPMI1640
培养液,
p>
37
,
C5%COZ
培养
7d
,
需要时补充新鲜培养液。
5d
后,
加入
LPS(lug/ml
,
Sigma)
培养
2d
后形成成熟
DC
,
r
照射使其失去增殖活性。将经过照射的
DC
与抗原肽
(10u
mol/l)
在培养液中,
37
℃<
/p>
5%CO2
共孵过夜。将
l*105
p>
负载有抗原肽的
DC
与
1x106
自体
PBMC
种于
p>
含
10%FCS
的
RPMI1640
完全培养液的
24
孔
细胞培养板,
37
℃
5%coZ
混合培养
3d
后,加入
rIL-2(20U/ml
,
Sigma)
< br>继续培养
10d
,进行细胞增殖实验和细胞活性
检测。
---------------
p>
结核杆菌抗原
CD8+T
细胞多表位
“
串珠式
”
肽疫苗研
究
第二军医
大学长征医院实验诊断科
仲人前
6
.
(一)人外周血单核细胞来源的
DCs
的培养
1
)
.外周血单核细胞的分离
HAL-A2.1+
小
PEBP+4
乳腺癌病人抗凝外周全血来自长海医
院和长征医院外科。
通过淋巴细胞分离液
(Ficoll-
Histopaque 1.077)
密度梯度离心
(
室温,
400×
g
,<
/p>
30
分
钟
)
p>
,取界面细胞,置入
50ml
离心管中,用
无钙镁
PBS(pH7.2)-EDAT(2mM)
悬浮细胞
,之后离心
(300×
g
,
10
分钟
)
洗细胞一次,
弃上清,无钙镁
PBS
重悬细
胞,再此
离心
(200×
g
,
< br>5
分钟
)
洗细胞
2
次,以便洗尽血小板。之后所获得的细胞
-
-
-
-
-
-
-
-
-
上一篇:大学英语(四)模拟题2及答案
下一篇:【最新】Miniver Cheevy赏析